Integrated Diagnostics Holdings plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IDGXF research report →
About the company
Integrated Diagnostics Holdings plc (IDGXF) functions as a consumer-focused healthcare enterprise, primarily dedicated to providing a comprehensive array of medical diagnostic services for patients. Its extensive service portfolio encompasses approximately 2,000 distinct diagnostic examinations, spanning diverse fields such as immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company maintains an operational footprint across Egypt, Jordan, Sudan, and Nigeria.
- CEO
- Hend El Sherbini
- IPO
- 2019
- Employees
- 6,309
- HQ
- Saint Helier, JE
Price Chart
- Market Cap
- $287.58M
- P/E
- 20.21
- P/S
- 3.73
- P/B
- 4.59
- EV/EBITDA
- 14.48
- Div Yield
- 5.08%
- Gross Margin
- 40.36%
- Op Margin
- 23.76%
- Net Margin
- 18.54%
- ROE
- 22.82%
- ROIC
- 12.79%
- Revenue
- $7.86B · 37.34%
- Net Income
- $1.26B · 17.15%
- EPS
- $2.17 · 19.23%
- Op Income
- $2.12B
- FCF YoY
- 2.93%
- 52W High
- $0.70
- 52W Low
- $0.32
- 50D MA
- $0.59
- 200D MA
- $0.61
- Beta
- 0.38
- Avg Volume
- 136
Get TickerSpark's AI analysis on IDGXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IDGXF coverage
Recent articles, reports, and earnings notes.
No research on IDGXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IDGXF report →Similar companies
Peers in the same neighborhood.